Clinical Trial Update: Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing indocyanine green angiography changes in choroidal neovascularization during ranibizumab treatment for exudative age-related ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Pusan National University Hospital | Conditions: Exudative Age-related Macular Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2014-04-07